静脉-静脉体外膜氧合期间获得性冯·维勒布兰德综合征与血小板功能受损:快速发生与快速恢复
该研究在59例接受静脉-静脉体外膜氧合(vvECMO)的患者中检测血管性血友病因子(VWF)参数、血小板聚集及颗粒分泌,发现所有患者在ECMO植入数小时后即出现严重获得性冯·维勒布兰德综合征(AVWS)和血小板功能障碍;撤机后60%在3小时内、86%在6小时内、全部在1天内恢复,提示撤机后呈高凝状态。
要点
- 所有vvECMO患者在植入数小时后即出现严重获得性冯·维勒布兰德综合征。
- 撤机后获得性冯·维勒布兰德综合征恢复迅速:60%在3小时内、86%在6小时内、全部在1天内恢复。
- 血小板聚集实验显示ADP、瑞斯托霉素、胶原和肾上腺素刺激后聚集低下,流式细胞术显示CD62和CD63表达严重降低。
核心结论
- 所有接受vvECMO支持的患者均快速发生获得性冯·维勒布兰德综合征和血小板功能障碍,导致凝血严重受损。
- 撤机后获得性冯·维勒布兰德综合征绝大多数在数小时内恢复,形成高凝状态。
- 这些发现增强了对减少剪切应力的新型体外技术的需求,并将ECMO期间强化抗凝的重点转移至撤机后时间点。
研究设计与样本
- 在大学ECMO中心接受vvECMO治疗的59例患者中,于ECMO植入前、治疗期间及撤机后获取血管性血友病因子参数。
- 在部分患者亚组中进行了血小板透光聚集实验和血小板颗粒分泌的流式细胞术定量。
主要发现
- 所有患者在vvECMO植入数小时后均出现严重获得性冯·维勒布兰德综合征。
- 撤机后获得性冯·维勒布兰德综合征在60%患者中3小时内恢复,86%患者6小时内恢复,全部患者1天内恢复。
- 血小板聚集实验显示ADP、瑞斯托霉素、胶原和肾上腺素刺激后血小板聚集低下。
- 流式细胞术血小板分析显示CD62和CD63表达严重降低。
临床怎么用
- 作者认为这些发现增强了对减少剪切应力的新型体外技术的需求。
- 作者认为这些发现将ECMO期间强化抗凝的重点转移至撤机后时间点。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bleeding contributes to the high mortality of venovenous extracorporeal membrane oxygenation (vvECMO). The development of acquired von Willebrand syndrome (AVWS) has been identified as relevant pathology during ECMO. This study was performed to determine the onset of AVWS after implantation and the recovery of von Willebrand factor (VWF) parameters after explantation of ECMO in a large cohort of patients. METHODS: VWF parameters of 59 patients treated with vvECMO at a university ECMO center were obtained before ECMO implantation, during therapy, and after explantation. In a subgroup of patients, light transmission aggregometry of platelets and flow-cytometric quantification of platelet granule secretion were performed. RESULTS: All patients developed severe AVWS hours after implantation of vvECMO. After explantation, AVWS recovered within 3 hours in 60%, within 6 hours in 86%, and in all patients within 1 day. Aggregometry showed hypoaggregability of platelets after stimulation with ADP, ristocetin, collagen, and epinephrine. Flow-cytometric platelet analyses revealed severely reduced expression of CD62 and CD63. CONCLUSIONS: All patients during vvECMO support rapidly develop AVWS and platelet dysfunction, resulting in severe impairment of coagulation. After explantation, AVWS overwhelmingly recovers within hours, resulting in a hypercoagulative state. These findings augment the need for novel extracorporeal technologies with reduced shear stress, and shift the emphasis for intense anti-coagulation during ECMO instead to a time-point after explantation.
引用
- Kalbhenn J, Schlagenhauf A, Rosenfelder S, et al. Acquired von Willebrand syndrome and impaired platelet function during venovenous extracorporeal membrane oxygenation: Rapid onset and fast recovery. J Heart Lung Transplant. 2018. PMID: 29650295. doi:10.1016/j.healun.2018.03.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。